论文部分内容阅读
目的评价尼莫通治疗重症脑出血的疗效。方法治疗组 2 2例 ,常规治疗基础上加用尼莫通 5 0 ml静脉滴注 ,每日 1次 ,10天一疗程 ;对照组 30例 ,仅用常规治疗 ,4周后比较两组疗效。结果治疗组总有效率 6 3.7%,对照组 43.3%,两组比较有显著性差异( P<0 .0 5 )。结论尼莫通治疗重症脑出血明显提高疗效。
Objective To evaluate the efficacy of Nimotop in the treatment of severe cerebral hemorrhage. Methods Twenty-two patients in the treatment group were treated with intravenous infusion of Nimotop (50 ml) once a day for routine treatment and 10 days for one course of treatment. In the control group, 30 patients were treated with conventional therapy alone. After 4 weeks, the efficacy of the two groups was compared. . Results The total effective rate in the treatment group was 63.7%, and that in the control group was 43.3%. There was a significant difference between the two groups (P<0.05). Conclusion Nimotop significantly improves the efficacy of severe cerebral hemorrhage.